Drug treatment of erection disorders in patients with cardiovascular disease;Medicamenteuze behandeling van erectiestoornissen bij cardiovasculair belaste patiënten

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 4, 2001, Pages 167-171

  Meuleman, E J H ^a,b   Kingma, J H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRIC OXIDE DONOR; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; SILDENAFIL;

CARDIOVASCULAR DISEASE; DRUG CONTRAINDICATION; DRUG INTERACTION; HUMAN; IMPOTENCE; MALE; NETHERLANDS; PRACTICE GUIDELINE; REVIEW;

CARDIOVASCULAR DISEASES; DRUG INTERACTIONS; HUMANS; IMPOTENCE; ISOSORBIDE DINITRATE; MALE; NETHERLANDS; NITRIC OXIDE DONORS; NITROGLYCERIN; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PRACTICE GUIDELINES;

EID: 0035956802     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-404.
2. Meuleman EJH, Berkel JTH van, Rabsztyn P, Damen L. Sildenafil (Viagra) voor de behandeling van erectiestoornissen. Ned Tijdschr Geneeskd 1998;142:2337-41.
3. Deventer CP van, Meuleman EJH, Bierkens PB, Sabbe BGC, Smals AGH. Ervaringen met intracaverneuze auto-injectie ter behandeling van erectiestoornissen. Ned Tijdschr Geneeskd 1993;137:408-12.
4. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000;163:460-3.
5. Levine GN, Keaney jr JF, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-21.
6. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-61.
7. Azadzoi KM, Goldstein I, Siroky MB, Traish AM, Krane RJ, Saenz de Tejada I. Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction. J Urol 1998;160(6 Pt 1):2216-22.
8. Cheitlin MD, Hutter jr AM, Brindis RG, Ganz P, Kaul S, Russell jr RO, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999; 33:273-82.
9. Littler WA, Honour AJ, Seight P. Direct arterial pressure, heart rate and electrocardiogram during human coitus. J Reprod Fertil 1974; 40:321-31.
10. Nemec ED, Mansfield L, Kennedy JW. Heart rate and blood pressure responses during sexual activity in normal males. Am Heart J 1976;92:274-7.
11. Bohlen JG, Held JP, Sanderson MO, Patterson RP. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med 1984;144:1745-8.
12. Wilson PK, Farday PS, Froelicher VF, editors. Cardiac rehabilitation: adult fitness and exercise testing. Philadelphia: Lea & Febiger; 1981. p. 333-53.
13. Jackson G, Betteridge J, Dean J, Hall R, Holdright D, Holmes S, et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract 1999;53:445-51.
14. Muller JE. Sexual activity as a trigger for cardiovascular events: what is the risk? Am J Cardiol 1999;84:2N-5N.
15. Jackson G, Benjamin N, Jackson N, Allen MJ. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 1999;83:13C-20C.
16. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69-74.
17. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med 2000;342:1622-6.
18. Steers WD. Viagra - after one year. Urology 1999;54:12-7.
19. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69-74.
20. Viagra (Sildenafil) 'Joint clinical review' for NDA-20-895. Rockville: FDA Center for Drug Evaluation and Research; 1998.
21. Feenstra J, Drie-Pierik RJHM van, Laclé CF, Stricker BHCh. Acute myocardial infarction associated with sildenafil [letter]. Lancet 1998;352:957-8.
22. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999;83:21C-8C.
23. Meuleman EJH, Donkers LHC, Robertson C, Keech M, Boyle P, Kiemeney LALM. Erectiele disfunctie: voorkomen en invloed op kwaliteit van leven. Dc Boxmeer studie. Ned Tijdschr Geneeskd [ter perse].
24. Meuleman EJH, Drenth J, Driel MF van. Lycklama à Nijeholt AAB. Richtlijnen voor diagnostick en behandeling van erectiestoornissen. Ned Tijdschr Geneeskd 1995;139:1874-9.
25. Meuleman EJH, Broderick G, Meng Tan H, Montorsi F, Sharlip I, Vardi Y. Clinical evaluation and the doctor-patient dialogue. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R, editors. Erectile dysfunction. Plymouth: Plymbridge Distributors; 2000. p. 115-38.
26. Rosen R, Goldstein I, Padma-Nathan H. The process of care model for evaluation and treatment of erectile dysfunction. Int J Impot Res 1999;11:59-74.
27. Montorsi F. Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:73-4.
28. Deckers JW, Berkel TFM van, Post F, Remme WJ, Veerhoek MJ. Hoge prevalentie van cardiovasculaire risicofactoren bij patiënten behandeld wegens coronaire hartziekte. Ned Tijdschr Geneeskd 1998;142:2737-42.
29. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-8.
30. Graaf J de, Stalenhoef AFH. Het gebruik van margarine verrijkt met fytosterolen als functioneel voedingsmiddel. Ned Tijdschr Geneeskd 2000;144:918-21.
31. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.
32. Knopp RH. Drug treatment of lipid disorders. N Engl J Med 1999;341:498-511.
33. Simoons ML, Casparie AF. Behandeling en preventie van coronaire hartziekten door verlaging van de serumcholesterolconcentratie; derde consensus 'Cholesterol'. Ned Tijdschr Geneeskd 1998;142: 2096-101.
34. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999;341:427-34.
35. Nemec ED, Mansfield L, Kennedy JW. Heart rate and blood pressure responses during sexual activity in nonnal males. Am Heart J 1976;92:274-7.